These are interesting points, I hope they are valid, but at this point I am assuming a complete loss on this investment. I will hold until they either go bankrupt or become successful. I think it is plausible that they only got low ball offers and felt it was better to take a dillution hit than sell out cheap. My concern is will there be more dillution needed before we get an FDA decision, in any case I am assuming the worst, so from here on there is only upside for me.
Idiots, there could have been dilution without selling shareholders down the river. Small dilution was expected to raise a small amount of money, perhaps a bridge loan or preferred shares convertible at a higher price.
6M shares and 13M warrants at .85 is INSANE.!!!!!
This BS about low ball offers is tedious. Partnership deals are signed every day. How are those companies able to get deals but Sunil can't?
If an asset is valued at $10M, do you really think that a major company comes in with an offer $1M? Who came up with this low ball theory? If Merck or GSK are interested in an asset, they make a reasonable offer. They don't waste anybody's time with low ball nonsense.
Face it, Sunil is just incompetent, plain and simple. Today's financing proves it.
Your argument/comments would suggest that there are no interested parties then for Probuphine because no one has stepped up to the plate, maybe Sunil is incompentent, maybe he isn't. Maybe Probuphine is not what we hoped it to be and nobody wanted to make an offer after kicking the tires. I hate to hope that Sunil is incompetent but the alternative explanations of no deal in hand are even more concerning at this point.